glp-1 chicago weight-loss drugs might help protect against breast cancer, study presented at ASCO meeting suggests Medicare opens GLP-1 weight-loss access
Description
The weight loss platform Noom recently launched its compounded GLP-1 microdose injections that claim to promote weight loss with fewer side effects.
A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults
Subgroup analysis for treatment durations6 months indicated a higher WL in the GLP-1RAs group (SMD=0.79, 95% CI 0.25 to 1.34)
Its dangerous, but for people like this author, the risks feel worth it.
A new daily pill called orforglipron helped adults lose weight and improve blood sugar levels in long global trials.
While these medications can help regulate appetite and support weight loss, sustainable success comes from pairing them with smart, supportive choices
